Pfizer not only beat expectations last quarter, but also boosted its guidance.

Markets have turned upbeat amid optimism that the 39-day US shutdown could soon come to an end, after a weekend of dealmaking ...

In early April, the S&P 500 entered bear market territory, defined by a 20% decline from its recent peak. The index fell to 4,870, down 21% from its high of 6,144 on February 19, 2025. This marks the ...

COPENHAGEN (Reuters) -Shares in Novo Nordisk rose on Monday after the Wegovy maker lost out to Pfizer in a $10 billion ...